112247 ⎘
Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
Sub-classes:METHODS OF REPEAT DOSING AND ADMINISTRATION OF LIPID PARTICLES OR VIRAL VECTORS AND RELATED SYSTEMS AND USES
#2VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#3NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE
#4METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
#5FUSOSOME COMPOSITIONS FOR T CELL DELIVERY
#6VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#7Methods and compositions for the activation of gamma-delta T-cells
#8Polynucleotide for modifying target sequence and use thereof
#9Methods and compositions for the activation of gamma-delta T-cells
#10Avian Cells for Improved Virus Production
#11VSV/NDV hybrid viruses for oncolytic therapy of cancer
#12Methods and compositions for protein delivery
#13Nipah virus envelope pseudotyped lentiviruses and methods of their use
#14Methods and compositions for the activation of gamma-delta T-cells
#15FILOVIRUS VECTORS AND PARTICLES PRODUCED THEREFROM
#16Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
#17Human ebola virus species and compositions and methods thereof
#18Nipah virus envelope pseudotyped lentiviruses and methods of their use
#19Lentiviral vectors
#20Methods and compositions for protein delivery
#21Chicken cells for improved virus production
#22NOVEL PSEUDOTYPED LENTIVIRAL PARTICLES AND THEIR USE IN THE IN VITRO TARGETED TRANSDUCTION OF UNDIFFERENTIATED PLURIPOTENT HUMAN EMBRYONIC STEM CELLS AND INDUCED PLURIPOTENT STEM CELLS
#23Human Ebola virus species and compositions and methods thereof
#24Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
#25Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors
#26Synthetic viruses and uses thereof
#27Vectors and methods for transducing B cells
#28Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof
#29Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell
#30Human Ebola Virus Species and Compositions and Methods Thereof
#31Viral Vectors with Improved Properties
#32Vector utilizing borna disease virus and use thereof
#33Biomolecule Surface Display and Uses Thereof
#34LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#35Methods and compositions for protein delivery
#36CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES
#37Filovirus vectors and noninfectious filovirus-based particles
#38Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
#39LENTIVIRUS PSEUDOTYPED WITH INFLUENZA HEMAGGLUTININ AND METHODS OF USE
#40Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression
#41Filovirus vectors and noninfectious filovirus-based particles
#42AVIAN INFLUENZA VACCINE
#43VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS
#44CHIMERIC VIRUS-LIKE PARTICLES
#45Chimeric viral envelopes
#46GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#47MOMLV-BASED PSEUDOVIRION PACKAGING CELL LINE
#48Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell
#49Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#50Genetically engineered equine influenza virus and uses thereof
#51Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins
#52Nuclear transport nucleic acid delivery vector
#53Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#54Viral vectors with improved properties
#55Pseudotyped retrovirus with modified ebola glycoprotein
#56Peptide composition and method for delivering substances into the cytosol of cells
#57Methods for producing and using pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#58Pseudotyped viruses and methods for their use
#59Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#60Paramyxoviruses as gene transfer vectors to lung cells